Spots Global Cancer Trial Database for acute myelocytic leukemia
Every month we try and update this database with for acute myelocytic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" | NCT00155844 | Acute Myelocyti... Acute Lymphocyt... | 0 Years - | National Taiwan University Hospital | ||
| Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" | NCT00155844 | Acute Myelocyti... Acute Lymphocyt... | 0 Years - | National Taiwan University Hospital | ||
| Safety and Tolerability of HSC835 in Patients With Hematological Malignancies | NCT01474681 | Acute Myelocyti... Acute Lymphocyt... Chronic Myeloge... Myelodysplastic... Chronic Lymphoc... Marginal Zone L... Follicular Lymp... Large-cell Lymp... Lymphoblastic L... Burkitt's Lymph... High Grade Lymp... Mantle-cell Lym... Lymphoplasmacyt... | HSC835 | 10 Years - 55 Years | Novartis | |
| Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00152139 | Acute Lymphobla... Acute Myelocyti... Chronic Myeloid... Juvenile Myelom... Myelodysplastic... Hemoglobinuria,... Non-Hodgkin Lym... | Allogeneic Stem... Chemotherapy an... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Stem Cell Transplantation for Patients With Hematologic Malignancies | NCT00152139 | Acute Lymphobla... Acute Myelocyti... Chronic Myeloid... Juvenile Myelom... Myelodysplastic... Hemoglobinuria,... Non-Hodgkin Lym... | Allogeneic Stem... Chemotherapy an... | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML) | NCT00822094 | Acute Myeloid L... | CPX-351 Intensive Salva... | 18 Years - 65 Years | Jazz Pharmaceuticals | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) | NCT01167166 | Acute Myelocyti... Acute Lymphocyt... Myeloproliferat... Chronic Myeloid... | rigosertib | 18 Years - | Traws Pharma, Inc. | |
| Treatment of Patients With Myelodysplastic Syndrome or Acute Myelocytic Leukemia With an Impending Hematological Relapse With Azacitidine (Vidaza) | NCT01462578 | Acute Myelocyti... Myelodysplastic... | Azacitidine | 18 Years - | Technische Universität Dresden | |
| Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML | NCT02255162 | Acute Myeloid L... Acute Myelocyti... Acute Myelogeno... Acute Granulocy... Acute Non-Lymph... | Lenalidomide HLA-mismatched ... Cytarabine | 18 Years - 75 Years | Massachusetts General Hospital | |
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia | NCT03796390 | Acute Myelocyti... | CD123 CAR-T cel... | 2 Years - 65 Years | Hebei Senlang Biotechnology Inc., Ltd. | |
| Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia | NCT02244658 | Antineoplastic ... Thrombocytopeni... Acute Myelocyti... | rhTPO | 15 Years - 75 Years | Shandong University | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant | NCT01621477 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Juvenile Myelom... Myelodysplastic... Hodgkin or Non-... Sarcoma, Myeloi... | clofarabine cytarabine busulfan Plerixafor cyclophosphamid... antithymocyte g... stem cells Tacrolimus mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies | NCT01188798 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Hodgkin's Disea... Myelodysplastic... | Methotrexate Pentostatin | 18 Months - 21 Years | St. Jude Children's Research Hospital | |
| A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia | NCT00559091 | Acute Myelocyti... | ribavirin | 18 Years - | Jewish General Hospital | |
| Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Myelocytic Leukemia | NCT03796390 | Acute Myelocyti... | CD123 CAR-T cel... | 2 Years - 65 Years | Hebei Senlang Biotechnology Inc., Ltd. | |
| Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | NCT01809392 | Acute Myelocyti... Myelodysplastic... | decitabine | 18 Years - 55 Years | The First Affiliated Hospital of Soochow University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
